| Literature DB >> 24763292 |
Lisa G Aspinwall1, Jennifer M Taber1, Wendy Kohlmann2, Samantha L Leaf1, Sancy A Leachman3.
Abstract
PURPOSE: Reducing ultraviolet radiation exposure may decrease melanoma risk in the hereditary melanoma setting. It is unknown whether genetic counseling and test reporting of CDKN2A/p16 mutation status promote long-term compliance with photoprotection recommendations, especially in unaffected mutation carriers.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24763292 PMCID: PMC4209010 DOI: 10.1038/gim.2014.37
Source DB: PubMed Journal: Genet Med ISSN: 1098-3600 Impact factor: 8.822
Figure 1Recruitment, retention, and attrition of noncarriers, unaffected carriers, and affected carriers at baseline and 2-year follow-up.
a One began study participation after the seasonal cutoff date (an eligibility criterion intended to provide seasonal adjustment for measures of photoprotection). The other two were not invited to the follow-up study because one participant was adopted and the other was from a small kindred. Given the focus on family communication and other familial issues in other parts of the questionnaire, it was decided that these participants' experience with genetic counseling and test reporting would be substantially different from the experiences of other participants.
b Retention rates for the 2-year follow-up assessment were calculated out of the 57 eligible participants (26 unaffected noncarriers, 15 unaffected carriers, and 16 affected carriers) who were invited to the follow-up study.
Figure 2Percent of time in the past 6 months participants reported using each of the recommended sun-protection behaviors (using sunscreen, wearing protective clothing, avoiding peak UVR exposure, seeking shade) at baseline and 2 years following melanoma genetic test reporting for A) unaffected noncarriers, B) unaffected carriers, and C) affected carriers.
*p<.05, ^p<.10
Figure 3Reported daily routine use of sunscreen, protective clothing, and UVR avoidance at baseline and 2 years following melanoma genetic test reporting for A) unaffected noncarriers, B) unaffected carriers, and C) affected carriers.
*p<.05 ^p<.10